These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


239 related items for PubMed ID: 18412306

  • 1. Longterm visual prognosis of patients with ocular Adamantiades-Behçet's disease treated with interferon-alpha-2a.
    Krause L, Altenburg A, Pleyer U, Köhler AK, Zouboulis CC, Foerster MH.
    J Rheumatol; 2008 May; 35(5):896-903. PubMed ID: 18412306
    [Abstract] [Full Text] [Related]

  • 2. Treatment of ocular symptoms of Behçet's disease with interferon alpha 2a: a pilot study.
    Kötter I, Eckstein AK, Stübiger N, Zierhut M.
    Br J Ophthalmol; 1998 May; 82(5):488-94. PubMed ID: 9713053
    [Abstract] [Full Text] [Related]

  • 3. Vitrectomy and trabeculectomy combined with interferon alpha treatment in Adamantiades-Behçet's disease: a case report.
    Krause L, Hoffmann F, Zouboulis CC, Foerster MH.
    Graefes Arch Clin Exp Ophthalmol; 2003 Oct; 241(10):871-4. PubMed ID: 13680252
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Long-term remission after cessation of interferon-α treatment in patients with severe uveitis due to Behçet's disease.
    Deuter CM, Zierhut M, Möhle A, Vonthein R, Stöbiger N, Kötter I.
    Arthritis Rheum; 2010 Sep; 62(9):2796-805. PubMed ID: 20518075
    [Abstract] [Full Text] [Related]

  • 8. Interferon alfa-2a in the treatment of ocular Adamantiades-Behçet's disease.
    Krause L, Turnbull JR, Torun N, Pleyer U, Zouboulis CC, Foerster MH.
    Adv Exp Med Biol; 2003 Sep; 528():511-9. PubMed ID: 12918754
    [No Abstract] [Full Text] [Related]

  • 9. Treatment of Adamantiades-Behçet disease with systemic interferon alfa.
    Zouboulis CC, Orfanos CE.
    Arch Dermatol; 1998 Aug; 134(8):1010-6. PubMed ID: 9722733
    [Abstract] [Full Text] [Related]

  • 10. Intraocular surgery under systemic interferon-alpha therapy in ocular Adamantiades-Behçet's disease.
    Krause L, Altenburg A, Bechrakis NE, Willerding G, Zouboulis CC, Foerster MH.
    Graefes Arch Clin Exp Ophthalmol; 2007 Nov; 245(11):1617-21. PubMed ID: 17431663
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of corticosteroids and cyclosporin in the treatment of retinal vasculitis in patients with Behçet's disease.
    Ermakova NA.
    Adv Exp Med Biol; 2003 Nov; 528():563-5. PubMed ID: 12918765
    [No Abstract] [Full Text] [Related]

  • 12. Combination of pulse cyclophosphamide and azathioprine in ocular manifestations of Behcet's disease: longitudinal study of up to 10 years.
    Davatchi F, Sadeghi Abdollahi B, Shams H, Shahram F, Nadji A, Chams-Davatchi C, Faezi T, Akhlaghi M, Ghodsi Z, Ashofteh F, Mohtasham N.
    Int J Rheum Dis; 2014 May; 17(4):444-52. PubMed ID: 24314325
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Safety and effectiveness of interferon alpha-2a in treatment of patients with Behçet's uveitis refractory to conventional treatments.
    Sobaci G, Erdem U, Durukan AH, Erdurman C, Bayer A, Köksal S, Karagul S, Bayraktar MZ.
    Ophthalmology; 2010 Jul; 117(7):1430-5. PubMed ID: 20417563
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Optic neuropathy in Behçet's disease: a series of 18 patients].
    Frigui M, Kechaou M, Jemal M, Ben Zina Z, Feki J, Bahloul Z.
    Rev Med Interne; 2009 Jun; 30(6):486-91. PubMed ID: 19375828
    [Abstract] [Full Text] [Related]

  • 17. Clinical Experience of Interferon Alfa-2a Treatment for Refractory Uveitis in Behçet's Disease.
    Park JY, Chung YR, Lee K, Song JH, Lee ES.
    Yonsei Med J; 2015 Jul; 56(4):1158-62. PubMed ID: 26069144
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of interferon alpha in the treatment of refractory and sight threatening uveitis: a retrospective monocentric study of 45 patients.
    Bodaghi B, Gendron G, Wechsler B, Terrada C, Cassoux N, Huong du LT, Lemaitre C, Fradeau C, LeHoang P, Piette JC.
    Br J Ophthalmol; 2007 Mar; 91(3):335-9. PubMed ID: 17050581
    [Abstract] [Full Text] [Related]

  • 19. [Adamantiades-Behcet's disease].
    Krause L.
    Ophthalmologe; 2005 Apr; 102(4):329-34. PubMed ID: 15668761
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.